Centro Cardiologico Monzino IRCCS Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2019
NCT03809494
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Centro Cardiologico Monzino | Centro Cardiologico Monzino IRCCS